276 related articles for article (PubMed ID: 25182519)
21. Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia.
Reis LM; Costakos D; Wheeler PG; Bardakjian T; Schneider A; Fung SSM; ; Semina EV
Clin Genet; 2021 Mar; 99(3):437-442. PubMed ID: 33314030
[TBL] [Abstract][Full Text] [Related]
22. Three cases with unusual ophthalmic phenotypes of congenital aniridia.
Lee NY; Lee YE; Mok J; Kim M; Park SH
Can J Ophthalmol; 2013 Aug; 48(4):340-2. PubMed ID: 23931477
[TBL] [Abstract][Full Text] [Related]
23. Histopathological characterisation of effects of the mouse Pax6(Leca4) missense mutation on eye development.
Ramaesh T; Williams SE; Paul C; Ramaesh K; Dhillon B; West JD
Exp Eye Res; 2009 Aug; 89(2):263-73. PubMed ID: 19345209
[TBL] [Abstract][Full Text] [Related]
24. A family with Axenfeld-Rieger syndrome and Peters Anomaly caused by a point mutation (Phe112Ser) in the FOXC1 gene.
Honkanen RA; Nishimura DY; Swiderski RE; Bennett SR; Hong S; Kwon YH; Stone EM; Sheffield VC; Alward WL
Am J Ophthalmol; 2003 Mar; 135(3):368-75. PubMed ID: 12614756
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation in the FOXC1 gene in a family with Axenfeld-Rieger syndrome and Peters' anomaly.
Weisschuh N; Wolf C; Wissinger B; Gramer E
Clin Genet; 2008 Nov; 74(5):476-80. PubMed ID: 18498376
[TBL] [Abstract][Full Text] [Related]
26. Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1.
Prokudin I; Simons C; Grigg JR; Storen R; Kumar V; Phua ZY; Smith J; Flaherty M; Davila S; Jamieson RV
Eur J Hum Genet; 2014 Jul; 22(7):907-15. PubMed ID: 24281366
[TBL] [Abstract][Full Text] [Related]
27. Identification of PITX3 mutations in individuals with various ocular developmental defects.
Zazo Seco C; Plaisancié J; Lupasco T; Michot C; Pechmeja J; Delanne J; Cottereau E; Ayuso C; Corton M; Calvas P; Ragge N; Chassaing N
Ophthalmic Genet; 2018 Jun; 39(3):314-320. PubMed ID: 29405783
[TBL] [Abstract][Full Text] [Related]
28. Peters anomaly: review of the literature.
Bhandari R; Ferri S; Whittaker B; Liu M; Lazzaro DR
Cornea; 2011 Aug; 30(8):939-44. PubMed ID: 21448066
[TBL] [Abstract][Full Text] [Related]
29. PAX6 mutation in association with ptosis, cataract, iris hypoplasia, corneal opacification and diabetes: a new variant of familial aniridia?
Peter NM; Leyland M; Mudhar HS; Lowndes J; Owen KR; Stewart H
Clin Exp Ophthalmol; 2013 Dec; 41(9):835-41. PubMed ID: 23566044
[TBL] [Abstract][Full Text] [Related]
30. Autosomal dominant cataracts and Peters anomaly in a large Australian family.
Withers SJ; Gole GA; Summers KM
Clin Genet; 1999 Apr; 55(4):240-7. PubMed ID: 10361984
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic Spectrum of Peters Anomaly: Implications for Management.
Elbaz U; Ali A; Strungaru H; Mireskandari K
Cornea; 2022 Feb; 41(2):192-200. PubMed ID: 34176915
[TBL] [Abstract][Full Text] [Related]
32. Ocular Manifestations of Peters Plus-Like Syndrome in 8q21.11 Microdeletion Syndrome.
Shigeyasu C; Yamada M; Miyata Y; Uchiyama Y; Matsumoto N; Kusumi Y; Shiraishi A
Cornea; 2023 Jul; 42(7):908-911. PubMed ID: 37039706
[TBL] [Abstract][Full Text] [Related]
33. Missense mutation in the alternative splice region of the PAX6 gene in eye anomalies.
Azuma N; Yamaguchi Y; Handa H; Hayakawa M; Kanai A; Yamada M
Am J Hum Genet; 1999 Sep; 65(3):656-63. PubMed ID: 10441571
[TBL] [Abstract][Full Text] [Related]
34. A novel de novo duplication mutation of PAX6 in a Chinese family with aniridia and other ocular abnormalities.
Zhuang J; Chen X; Tan Z; Zhu Y; Zhao K; Yang J
Sci Rep; 2014 May; 4():4836. PubMed ID: 24787241
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis and genotype-phenotype correlations in southern Indian patients with sporadic and familial aniridia.
Dubey SK; Mahalaxmi N; Vijayalakshmi P; Sundaresan P
Mol Vis; 2015; 21():88-97. PubMed ID: 25678763
[TBL] [Abstract][Full Text] [Related]
36. Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia.
Brémond-Gignac D; Bitoun P; Reis LM; Copin H; Murray JC; Semina EV
Mol Vis; 2010 Aug; 16():1705-11. PubMed ID: 20806047
[TBL] [Abstract][Full Text] [Related]
37. PAX6 mutation as a genetic factor common to aniridia and glucose intolerance.
Yasuda T; Kajimoto Y; Fujitani Y; Watada H; Yamamoto S; Watarai T; Umayahara Y; Matsuhisa M; Gorogawa S; Kuwayama Y; Tano Y; Yamasaki Y; Hori M
Diabetes; 2002 Jan; 51(1):224-30. PubMed ID: 11756345
[TBL] [Abstract][Full Text] [Related]
38. A novel, non-stop mutation in FOXE3 causes an autosomal dominant form of variable anterior segment dysgenesis including Peters anomaly.
Doucette L; Green J; Fernandez B; Johnson GJ; Parfrey P; Young TL
Eur J Hum Genet; 2011 Mar; 19(3):293-9. PubMed ID: 21150893
[TBL] [Abstract][Full Text] [Related]
39. A 556 kb deletion in the downstream region of the PAX6 gene causes familial aniridia and other eye anomalies in a Chinese family.
Cheng F; Song W; Kang Y; Yu S; Yuan H
Mol Vis; 2011 Feb; 17():448-55. PubMed ID: 21321669
[TBL] [Abstract][Full Text] [Related]
40. Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations.
Hingorani M; Williamson KA; Moore AT; van Heyningen V
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2581-90. PubMed ID: 19218613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
